LL-37
90,00$
Information
LL-37 is a naturally occurring, cationic antimicrobial peptide derived from the human cathelicidin antimicrobial protein (hCAP18). It plays a central role in innate immunity, exhibiting broad-spectrum antimicrobial, antiviral, and immunomodulatory effects. LL-37 is studied extensively for its functions in wound healing, host defense, inflammation, and tissue regeneration. Epigenetix Labs supplies LL-37 as a high-purity, research-grade peptide for laboratory use only. Not for human or veterinary use.
10 Research-Based Reasons to Study
- Exhibits broad-spectrum antimicrobial activity
- Inhibits bacterial, viral, and fungal pathogens
- Modulates immune cell recruitment and activation
- Promotes wound healing and tissue regeneration
- Reduces biofilm formation by pathogenic microbes
- Regulates inflammatory responses in epithelial tissues
- Enhances barrier function in skin and mucosa
- Demonstrates anti-tumor and anti-angiogenic effects
- Safe and effective in preclinical research models
- Enables studies on host defense, inflammation, and repair
Additional information
Additional information
| Weight | 0,006 kg |
|---|---|
| Dimensions | 1,5 × 1,5 × 3,5 cm |
| Research Applications | Infectious disease and antimicrobial research |
| Key Research Findings | Effective against Gram-positive and Gram-negative bacteria, enveloped viruses, and fungi |
| Scientific Background | LL-37 is the only cathelicidin-derived peptide found in humans. |
| Purity & Manufacturing Standards | Synthesized via solid-phase peptide synthesis (SPPS) |
| Legal Disclaimer | For laboratory research use only. Not for human or veterinary use. Not for therapeutic, diagnostic, or food applications. Not evaluated by the FDA or regulatory authorities. |
| Dimensions | 1,5 x 1,5 x 3 cm |
| Weight | 0,006 kg |
| Size | 10 mg |
Reviews
There are no reviews yet.